REATA PHARMACEUTICALS INC's ticker is RETA and the CUSIP is 75615P103. A total of 152 filers reported holding REATA PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is 3.61 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $744,308 | +12.1% | 7,300 | 0.0% | 0.00% | 0.0% |
| Q1 2023 | $663,716 | +178.9% | 7,300 | -19.2% | 0.00% | – |
| Q4 2021 | $238,000 | -78.6% | 9,030 | -18.1% | 0.00% | -100.0% |
| Q3 2021 | $1,110,000 | -28.9% | 11,030 | 0.0% | 0.00% | 0.0% |
| Q2 2021 | $1,561,000 | +38.3% | 11,030 | -2.6% | 0.00% | 0.0% |
| Q1 2021 | $1,129,000 | -19.4% | 11,330 | 0.0% | 0.00% | 0.0% |
| Q4 2020 | $1,400,000 | +59.1% | 11,330 | +25.5% | 0.00% | 0.0% |
| Q3 2020 | $880,000 | -81.7% | 9,030 | -70.7% | 0.00% | -83.3% |
| Q2 2020 | $4,803,000 | +48.4% | 30,783 | +37.2% | 0.01% | +50.0% |
| Q1 2020 | $3,237,000 | -2.6% | 22,429 | +38.0% | 0.00% | +33.3% |
| Q4 2019 | $3,322,000 | – | 16,251 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CPMG Inc | 2,896,901 | $291,457,000 | 32.14% |
| PARAGON ASSOCIATES & PARAGON ASSOCIATES II JOINT VENTURE | 46,646 | $4,693,000 | 5.31% |
| Ikarian Capital, LLC | 471,400 | $47,423,000 | 3.34% |
| Duquesne Family Office | 695,033 | $69,927,000 | 2.27% |
| Camber Capital Management LP | 685,000 | $68,918,000 | 2.12% |
| LBJ Family Wealth Advisors, Ltd. | 30,359 | $3,054,000 | 1.82% |
| MADDEN SECURITIES Corp | 33,127 | $3,333,000 | 1.80% |
| Biondo Investment Advisors, LLC | 104,120 | $10,475,000 | 1.80% |
| Tolleson Wealth Management, Inc. | 60,750 | $6,112,000 | 1.73% |
| Keel Point, LLC | 97,074 | $9,767,000 | 1.26% |